SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 67994.
  • 2
    DeNardo GL, DeNardo SJ, Macey DJ, Shen S, Kroger LA. Overview of radiation myelotoxicity secondary to radioimmunotherapy using I-131-Lym-1 as a model. Cancer 1994; 73(Suppl): 103848.
  • 3
    Siegel JA, Wessels BW, Waston EE, Stabin MG, Vriesendorp HM, Bradley EW, et al. Bone marrow dosimetry and toxicity for radioimmunotherapy. Antib Immunoconjug Radiopharm 1990; 3: 21333.
  • 4
    Meredith RF, Khazaeli MB, Liu T, Plott G, Wheeler RH, Russell C, Colcher D, et al. Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancer. J Nucl Med 1992; 33: 164853.
  • 5
    Sgouros G, Stabin M, Erdi Y, Akabani G, Kwok C, Brill AB, et al. Red marrow dosimetry for radiolabeled antibodies that bind to marrow, bone, or blood components. Med Phys 2000; 27: 215064.
  • 6
    Hendry JH, Lord BI. The analysis of the early and late response to cytotoxic insults in the haemopoietic cell hierarchy. In: PottenCS, HendryJH, editors. Cytotoxic insult to tissue. Edinburgh: Churchill-Livingstone; 1983: 166.
  • 7
    Shen S, DeNardo GL, Jones TD, Wilder RB, O'Donnell RT, DeNardo SJ. A preliminary cell kinetics model of thrombocytopenia after radioimmunotherapy. J Nucl Med 1998; 39: 12239.
  • 8
    Fowler JF. Radiobiological aspects of low dose rates in radioimmunotherapy. Int J Radiat Oncol Biol Phys 1990; 18: 12619.
  • 9
    O'Donoghue JA. The impact of tumor cell proliferation in radioimmunotherapy. Cancer 1994; 73: 97480.
  • 10
    Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 1985; 58: 51528.
  • 11
    Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 13146.
  • 12
    Withers HR. What TPOT is not. Int J Radiat Oncol Biol Phys 1996; 35: 6334.
  • 13
    Ebbe S. Origin, production and life-span of blood platelets. In: JohnsonSA, editor. The circulating platelet. New York: Academic Press, 1971: 1943.
  • 14
    Coggle JE. Absence of late radiation effects on bone marrow stem cells. Int J Radiat Biol 1980; 38: 58995.
  • 15
    Jones TD, Morris MD, Young RW. A mathematical model for radiation-induced myelopoiesis. Radiat Res 1991; 128: 25866.
  • 16
    Jones TD, Morris MD, Young RW. Mathematical models of marrow cell kinetics: differential effects of protracted irradiations on stromal and stem cells in mice. Int J Radiat Oncol Biol Phys 1993; 26: 81730.
  • 17
    O'Donoghue JA, Sgouros G, Divgi CR, Humm JL. Single-dose versus fractionated radioimmunotherapy: model comparisons for uniform tumor dosimetry. J Nucl Med 2000; 41: 53847.
  • 18
    Report of the Task Group on Reference Man. International Commission on Radiological Protection, No. 23. Oxford: Pergamon Press, 1974:38.
  • 19
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model. Clin Cancer Res 1999; 5(Suppl): 3153s3159s.
  • 20
    Blumenthal RD, Alisauskas R, Juweid M, Sharkey RM, Goldenberg DM. Defining the optimal spacing between repeat radioantibody doses in experimental models: is there an accurate measurement for hematopoietic recovery? Cancer 1997; 80(Suppl): 262435.